Answers are grounded in this paper and cite their sources.
Smart nanomedicine overcomes multidrug resistance in breast cancer therapy, suggesting improved outcomes for patients.
Docetaxel (DTX), a first-line taxane chemotherapeutic agent, is widely used in the treatment of breast cancer. However, its clinical efficacy is often limited by multidrug resistance (MDR), primarily driven by...
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: